Gamma Knife Market globally is expected to foresee a compound annual growth rate (CAGR) of 3.7% from 2020 to 2027. Gamma knife is advanced radiation therapy for the treatment of cancer as well as other diseases in patients. Gamma knife is a beam of highly focused gamma rays; which precisely cut the tumor or the damaged cells. Gamma knife therapy is generally used for the treatment of brain tumors, trigeminal neuralgia, nerve disorders, epilepsy which cause chronic pain, malformations, and other neurological disorders. It is a non-invasive surgical procedure with accuracy and precision. Gamma knife therapy is preferred by physicians across the healthcare sector owing to its safe treatment procedures.
Increased prevalence of malignant tumors such as cancer and brain tumors among others are driving the global gamma knife market. Adaptation of gamma knife therapy by various healthcare sectors owing to its accurate and précised treatment, non-invasive surgical procedure, developed and innovative technologies and high success rate are driving the global gamma knife market. The high procedure costs, lack of appropriate infrastructure and lack of skilled technicians, limited availability of equipment, and lack of awareness among people act as some of the major restraining factors for the global gamma knife market. However, the ongoing research and development would provide numerous opportunities in the gamma knife market during the forecast period.
The data and insights provided in this report on the global gamma knife market are a result of extensive primary as well as secondary research work by market analysts. The report highlights the competitive scenario within the global gamma knife market, ranking all the major players according to the key recent developments and their geographic extensions. This report incorporates in-depth analysis with the potential impact on micro-economic factors of the market, current market scenario, key trends and developments, prominent players and their business strategies along with the detailed company profiles.
The global gamma knife market is segmented into by indication and by geography covering the major countries across the major geographies. By indication, the global gamma knife market is segmented into Brain Metastasis, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others. By geography the region covered are North America, Europe, Asia Pacific and Rest of the World (RoW). North America covers the U.S., Mexico and Canada. Europe is further bifurcated into UK, Italy, Spain, Russia, France and Germany. China, India, Japan, South Korea, Taiwan, Singapore, Australia and rest of Asia Pacific. Rest of the World (RoW) covers South & Central America, Middle East and Africa.
Some of the leading players of global gamma knife market are Elekta, Mitsubishi Electric, BrainLab, Starmap, Medicine & TechnologyAccuray, Philips Healthcare, Hitachi America, GE Healthcare, Nordion, RaySearch, Sumitomo Heavy Industries, and Varian Medical Systems, among other prominent players.
North America dominates the global gamma knife market owing to the increased prevalence of cancer, surging demand for advanced and innovative surgical methods for the treatment of cancer, and rise in the adaptation of advanced technologies for curing cancer among the healthcare sectors. Besides, Europe is anticipated to attain the second-largest market share during the forecast period.
Scope of Global Gamma Knife Market Segments
The market is segmented on the basis of indication and geography.
Rest of the World (RoW)